PRECISION BIOSCIENCES INC — Director's Dealing 2024

Jan 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-01-20

Reporting Person: List Alan (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-20	Common Stock	M	60012	—	Acquired	116508	Direct
2024-01-22	Common Stock	S	21526	$0.36	Disposed	94982	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-20	Restricted Stock Units	$	M	60012	Disposed		Common Stock (60012)	Direct

Footnotes

F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F3: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 10, 2021. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F4: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.